|
1
|
De Rosa M, Rega D, Costabile V, Duraturo
F, Niglio A, Izzo P, Pace U and Delrio P: The biological complexity
of colorectal cancer: Insights into biomarkers for early detection
and personalized care. Therap Adv Gastroenterol. 9:861–886. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar
|
|
3
|
Peifer M: Developmental biology: Colon
construction. Nature. 420:274–275. 2772002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kosinski C, Li VS, Chan AS, Zhang J, Ho C,
Tsui WY, Chan TL, Mifflin RC, Powell DW, Yuen ST, et al: Gene
expression patterns of human colon tops and basal crypts and BMP
antagonists as intestinal stem cell niche factors. Proc Natl Acad
Sci USA. 104:15418–15423. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
De Rosa M, Pace U, Rega D, Costabile V,
Duraturo F, Izzo P and Delrio P: Genetics, diagnosis and management
of colorectal cancer (Review). Oncol Rep. 34:1087–1096. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gangemi R, Paleari L, Orengo AM, Cesario
A, Chessa L, Ferrini S and Russo P: Cancer stem cells: A new
paradigm for understanding tumor growth and progression and drug
resistance. Curr Med Chem. 16:1688–1703. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fanali C, Lucchetti D, Farina M, Corbi M,
Cufino V, Cittadini A and Sgambato A: Cancer stem cells in
colorectal cancer from pathogenesis to therapy: Controversies and
perspectives. World J Gastroenterol. 20:923–942. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar
|
|
9
|
Greaves M and Maley CC: Clonal evolution
in cancer. Nature. 481:306–313. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cano A, Pérez-Moreno MA, Rodrigo I,
Locascio A, Blanco MJ, del Barrio MG, Portillo F and Nieto MA: The
transcription factor snail controls epithelial-mesenchymal
transitions by repressing E-cadherin expression. Nat Cell Biol.
2:76–83. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li X, Pei D and Zheng H: Transitions
between epithelial and mesenchymal states during cell fate
conversions. Protein Cell. 5:580–591. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Loboda A, Nebozhyn MV, Watters JW, Buser
CA, Shaw PM, Huang PS, Van't Veer L, Tollenaar RA, Jackson DB,
Agrawal D, et al: EMT is the dominant program in human colon
cancer. BMC Med Genomics. 4:92011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dallas NA, Xia L, Fan F, Gray MJ, Gaur P,
van Buren G II, Samuel S, Kim MP, Lim SJ and Ellis LM:
Chemoresistant colorectal cancer cells, the cancer stem cell
phenotype, and increased sensitivity to insulin-like growth
factor-I receptor inhibition. Cancer Res. 69:1951–1957. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fan F, Samuel S, Evans KW, Lu J, Xia L,
Zhou Y, Sceusi E, Tozzi F, Ye XC, Mani SA, et al: Overexpression of
snail induces epithelial-mesenchymal transition and a cancer stem
cell-like phenotype in human colorectal cancer cells. Cancer Med.
1:5–16. 2012. View
Article : Google Scholar
|
|
15
|
Vichalkovski A, Gresko E, Hess D,
Restuccia DF and Hemmings BA: PKB/AKT phosphorylation of the
transcription factor Twist-1 at Ser42 inhibits p53 activity in
response to DNA damage. Oncogene. 29:3554–3565. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang Y, Pan X, Lei W, Wang J and Song J:
Transforming growth factor-beta1 induces epithelial-to-mesenchymal
transition and apoptosis via a cell cycle-dependent mechanism.
Oncogene. 25:7235–7244. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vega S, Morales AV, Ocaña OH, Valdés F,
Fabregat I and Nieto MA: Snail blocks the cell cycle and confers
resistance to cell death. Genes Dev. 18:1131–1143. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ong BA, Vega KJ and Houchen CW: Intestinal
stem cells and the colorectal cancer microenvironment. World J
Gastroenterol. 20:1898–1909. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Doherty MR, Smigiel JM, Junk DJ and
Jackson MW: Cancer stem cell plasticity drives therapeutic
resistance. Cancers (Basel). 8. pp. E82016, View Article : Google Scholar
|
|
20
|
Chaffer CL, San Juan BP, Lim E and
Weinberg RA: EMT, cell plasticity and metastasis. Cancer Metastasis
Rev. 35:645–654. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Grassilli E, Narloch R, Federzoni E,
Ianzano L, Pisano F, Giovannoni R, Romano G, Masiero L, Leone BE,
Bonin S, et al: Inhibition of GSK3B bypass drug resistance of
p53-null colon carcinomas by enabling necroptosis in response to
chemotherapy. Clin Cancer Res. 19:3820–3831. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McCubrey JA, Steelman LS, Bertrand FE,
Davis NM, Sokolosky M, Abrams SL, Montalto G, D'Assoro AB, Libra M,
Nicoletti F, et al: GSK-3 as potential target for therapeutic
intervention in cancer. Oncotarget. 5:2881–2911. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liccardo R, De Rosa M, Izzo P and Duraturo
F: Novel Implications in Molecular Diagnosis of Lynch Syndrome.
Gastroenterol Res Pract. 2017:25950982017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Costabile V, Duraturo F, Delrio P, Rega D,
Pace U, Liccardo R, Rossi GB, Genesio R, Nitsch L, Izzo P, et al:
Lithium chloride induces mesenchymal-to-epithelial reverting
transition in primary colon cancer cell cultures. Int J Oncol.
46:1913–1923. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liang CC, Park AY and Guan JL: In vitro
scratch assay: A convenient and inexpensive method for analysis of
cell migration in vitro. Nat Protoc. 2:329–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Paparo L, Rossi GB, Delrio P, Rega D,
Duraturo F, Liccardo R, Debellis M, Izzo P and De Rosa M:
Differential expression of PTEN gene correlates with phenotypic
heterogeneity in three cases of patients showing clinical
manifestations of PTEN hamartoma tumour syndrome. Hered Cancer Clin
Pract. 11:82013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Duraturo F, Liccardo R, Cavallo A, De Rosa
M, Rossi GB and Izzo P: Multivariate analysis as a method for
evaluating the pathogenicity of novel genetic MLH1 variants in
patients with colorectal cancer and microsatellite instability. Int
J Mol Med. 511–517. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Δ Δ C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
29
|
Galatola M, Paparo L, Duraturo F, Turano
M, Rossi GB, Izzo P and De Rosa M: Beta catenin and cytokine
pathway dysregu-lation in patients with manifestations of the 'PTEN
hamartoma tumor syndrome'. BMC Med Genet. 13:282012. View Article : Google Scholar
|
|
30
|
Angrisani A, Turano M, Paparo L, Di Mauro
C and Furia M: A new human dyskerin isoform with cytoplasmic
localization. Biochim Biophys Acta. 1810:1361–1368. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Di Maio N, Vicidomini R, Angrisani A,
Belli V, Furia M and Turano M: A new role for human dyskerin in
vesicular trafficking. FEBS Open Bio. 7:1453–1468. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Feng B, Dong TT, Wang LL, Zhou HM, Zhao
HC, Dong F and Zheng MH: Colorectal cancer migration and invasion
initiated by microRNA-106a. PLoS One. 7:e434522012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sato T, Stange DE, Ferrante M, Vries RG,
Van Es JH, Van den Brink S, Van Houdt WJ, Pronk A, Van Gorp J,
Siersema PD, et al: Long-term expansion of epithelial organoids
from human colon, adenoma, adenocarcinoma, and Barrett's
epithelium. Gastroenterology. 141:1762–1772. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sato T, Vries RG, Snippert HJ, van de
Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters
PJ, et al: Single Lgr5 stem cells build crypt-villus structures in
vitro without a mesenchymal niche. Nature. 459:262–265. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Weiswald LB, Bellet D and Dangles-Marie V:
Spherical cancer models in tumor biology. Neoplasia. 17:1–15. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yilmaz M and Christofori G: Mechanisms of
motility in metastasizing cells. Mol Cancer Res. 8:629–642. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
DI Domenico M, Pierantoni GM, Feola A,
Esposito F, Laino L, DE Rosa A, Rullo R, Mazzotta M, Martano M,
Sanguedolce F, et al: Prognostic significance of N-Cadherin
expression in oral squamous cell carcinoma. Anticancer Res.
31:4211–4218. 2011.PubMed/NCBI
|
|
39
|
LaBarge MA and Bissell MJ: Is CD133 a
marker of metastatic colon cancer stem cells? J Clin Invest.
118:2021–2024. 2008.PubMed/NCBI
|
|
40
|
Shmelkov SV, Butler JM, Hooper AT, Hormigo
A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, et
al: CD133 expression is not restricted to stem cells, and both
CD133+ and CD133- metastatic colon cancer cells initiate
tumors. J Clin Invest. 118:2111–2120. 2008.PubMed/NCBI
|
|
41
|
Cantile M, Collina F, D'Aiuto M, Rinaldo
M, Pirozzi G, Borsellino C, Franco R, Botti G and Di Bonito M:
Nuclear localization of cancer stem cell marker CD133 in
triple-negative breast cancer: A case report. Tumori. 99:e245–e250.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Nunukova A, Neradil J, Skoda J, Jaros J,
Hampl A, Sterba J and Veselska R: Atypical nuclear localization of
CD133 plasma membrane glycoprotein in rhabdomyosarcoma cell lines.
Int J Mol Med. 36:65–72. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Huang M, Zhu H, Feng J, Ni S and Huang J:
High CD133 expression in the nucleus and cytoplasm predicts poor
prognosis in non-small cell lung cancer. Dis Markers.
2015:9860952015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bessède E, Staedel C, Acuña Amador LA,
Nguyen PH, Chambonnier L, Hatakeyama M, Belleannée G, Mégraud F and
Varon C: Helicobacter pylori generates cells with cancer stem cell
properties via epithelial-mesenchymal transition-like changes.
Oncogene. 33:4123–4131. 2014. View Article : Google Scholar
|
|
45
|
Yan Y, Zuo X and Wei D: Concise Review:
Emerging role of CD44 in cancer stem cells: A promising biomarker
and therapeutic target. Stem. Cells Transl Med. 4:1033–1043. 2015.
View Article : Google Scholar
|
|
46
|
Lee JL, Wang MJ and Chen JY: Acetylation
and activation of STAT3 mediated by nuclear translocation of CD44.
J Cell Biol. 185:949–957. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Beurel E and Jope RS: The paradoxical pro-
and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic
apoptosis signaling pathways. Prog Neurobiol. 79:173–189. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Shakoori A, Ougolkov A, Yu ZW, Zhang B,
Modarressi MH, Billadeau DD, Mai M, Takahashi Y and Minamoto T:
Deregulated GSK3beta activity in colorectal cancer: Its association
with tumor cell survival and proliferation. Biochem Biophys Res
Commu. 334:1365–1373. 2005. View Article : Google Scholar
|
|
49
|
Shakoori A, Mai W, Miyashita K, Yasumoto
K, Takahashi Y, Ooi A, Kawakami K and Minamoto T: Inhibition of
GSK-3 beta activity attenuates proliferation of human colon cancer
cells in rodents. Cancer Sci. 98:1388–1393. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Fu Y, Jiao Y, Zheng S, Liang A and Hu F:
Combination of lithium chloride and pEGFP-N1-BmK CT effectively
decreases proliferation and migration of C6 glioma cells.
Cytotechnology. 68:197–202. 2016. View Article : Google Scholar :
|
|
51
|
Cockle JV, Picton S, Levesley J, Ilett E,
Carcaboso AM, Short S, Steel LP, Melcher A, Lawler SE and
Brüning-Richardson A: Cell migration in paediatric glioma;
characterisation and potential therapeutic targeting. Br J Cancer.
112:693–703. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Silva AK, Yi H, Hayes SH, Seigel GM and
Hackam AS: Lithium chloride regulates the proliferation of
stem-like cells in retinoblastoma cell lines: A potential role for
the canonical Wnt signaling pathway. Mol Vis. 16:36–45.
2010.PubMed/NCBI
|
|
53
|
Li H, Huang K, Liu X, Liu J, Lu X, Tao K,
Wang G and Wang J: Lithium chloride suppresses colorectal cancer
cell survival and proliferation through ROS/GSK-3β/NF-κB signaling
pathway. Oxid Med Cell Longev. 2014:2418642014. View Article : Google Scholar
|
|
54
|
Lee TY, Liu CL, Chang YC, Nieh S, Lin YS,
Jao SW, Chen SF and Liu TY: Increased chemoresistance via Snail-Raf
kinase inhibitor protein signaling in colorectal cancer in response
to a nicotine derivative. Oncotarget. 7:23512–23520.
2016.PubMed/NCBI
|
|
55
|
Sirri V, Urcuqui-Inchima S, Roussel P and
Hernandez-Verdun D: Nucleolus: The fascinating nuclear body.
Histochem Cell Biol. 129:13–31. 2008. View Article : Google Scholar
|
